Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 26, 2005Antimicrobial Agents and ChemotherapyOpen Access

Evidence for Reduction in Breakpoints Used To Determine Vancomycin Susceptibility in Staphylococcus aureus

View Full Paper
Ask AI
Bookmark
Share

Authors

MWMandy WoottonUniversity Hospital of WalesTWTimothy R. WalshGoethe University FrankfurtAMAlasdair MacGowanSouthmead Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wootton et al. (2005) studied this question.

synapsesocial.com/papers/6a95171fa9fda6dc960f3d2dhttps://doi.org/10.1128/aac.49.11.4819.2005
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Epidemiological and Microbiological Characterization of Infections Caused by<i>Staphylococcus aureus</i>with Reduced Susceptibility to Vancomycin, United States, 1997–20012003 · 346 citations
  2. 2National Committee for Clinical Laboratory Standards1980 · 14,792 citations
  3. 3A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital2001 · 415 citations